To evaluate dystrophin deficiency, the isolated cells were cultured in growth medium and harvested in a proliferative state, and a Western blot analysis using antibodies against the rod domain (DYS1) and the C-terminus (DYS2) of dystrophin was conducted. Here, DMD is linked to neuromuscular disease caused by qualitative or quantitative defects of dystrophin.